Press Releases

• Juvaris BioTherapeutics Initiates Phase I Clinical Trial of JVRS-100 Adjuvanted Seasonal Influenza Vaccine — 05.28.08

• Juvaris BioTherapeutics Announces the Appointment of Grant E. Pickering as Chief Executive Officer — 03.13.08

• Bayer HealthCare and Juvaris BioTherapeutics announce major licensing agreement — 03.04.08

• Carol L. Brosgart, M.D., Appointed to the Board of Directors of Juvaris BioTherapeutics, Inc. — 01.22.08

• Juvaris BioTherapeutics Announces Cooperative Research and Development Agreement with the Centers for Disease Control and Prevention — 01.15.08

• Juvaris Biotherapeutics Announces Five Scientific Presentations at Infectious Diseases Society of America (IDSA) Meeting October 6th, 2007 — 09.26.07

• Juvaris BioTherapeutics Announces Award of U01 Cooperative Research Partnership from NIAID — 07.31.07

• Lewis T. "Rusty" Williams, M.D., Ph.D. Appointed to the Board of Directors of Juvaris BioTherapeutics, Inc. — 06.06.07

• Juvaris BioTherapeutics Announces First Round Closing of Series A Financing — 01.08.07